Nexium, Lexapro Paragraph IV Certifications Filed
This article was originally published in The Pink Sheet Daily
Executive Summary
The first ANDA with a Paragraph IV certification for AstraZeneca's proton pump inhibitor Nexium (esomeprazole) was filed Aug. 5, according to FDA's Oct. 18 updated list of filings